FNY Investment Advisers’s Acceleron Pharma XLRN Stock Holding History

FNY Investment Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-240	Closed	-$41K	–	934
2021 Q3	$41K	Buy	+240	New	+$31.4K	0.02%	387
2018 Q4	–	Sell	-1,500	Closed	-$85K	–	1147
2018 Q3	$85K	Hold	1,500	–	–	0.02%	290
2018 Q2	$72K	Buy	+1,500	New	+$54.7K	0.03%	255

FNY Investment Advisers's XLRN Position: Q4 2021 in Review

FNY Investment Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 240 shares — an estimated $41K sold.

FNY Investment Advisers first reported a position in XLRN in Q2 2018 and held it in 3 quarters. The position peaked at $85K in Q3 2018. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

FNY Investment Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
FNY Investment Advisers sold 240 Acceleron Pharma shares in Q4 2021, an estimated $41K.
FNY Investment Advisers first reported a position in Acceleron Pharma in Q2 2018 and held it in 3 quarters.
FNY Investment Advisers's Acceleron Pharma position peaked at $85K in Q3 2018.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on FNY Investment Advisers's 13F filing for Q4 2021, filed 10 Jan 2022.